Biomarkers of Vascular Inflammation for Cardiovascular Risk Prognostication: A Meta-Analysis

March 2022

Publication: JACC: Cardiovascular Imaging, Volume 15, Issue 3

Source / Author: Alexios S.Antonopoulos MD, PhD, et. al

Measurement of biomarkers of vascular inflammation is advocated for the risk stratification for coronary heart disease (CHD). The purpose of this study was to systematically explore the added value of biomarkers of vascular inflammation for cardiovascular prognostication on top of clinical risk factors.

Read the full Article

Read more

Perivascular adipose tissue (PVAT) as a source of imaging biomarkers and a therapeutic target. FAI, fat attenuation index.

October 2023

Author: European Society of Cardiology Working Group

Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers: A clinical consensus statement from the European Society of Cardiology Working Group on Coronary Pathophysiology and Micro-circulation

This clinical consensus statement from the European Society of Cardiology defines perivascular adipose tissue (PVAT) and highlights the biological mechanisms…

Read more

SARS-CoV-2 vRNA in human coronary arteries from deceased individuals with COVID-19 is identified using AI-based spatial analysis.

October 2023

Author: Eberhardt, et al.

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels

Abstract: Patients with coronavirus disease 2019 (COVID-19) present increased risk for ischemic cardiovascular complications up to 1 year after infection. Although…